Home > Insider Trading > Filing (0001181431-10-057911)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1310094	Accentia Biopharmaceuticals Inc	ABPI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1066040	Jr E Francis Odonnell	865 Longboat Club Road Longboat Key FL 34228	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-24	750,000	$0.00	750,000	No	4	A	Direct
Common Stock	Acquisiton	2010-11-24	225,954	$0.99	638,846	No	4	P	Indirect	By: Hopkins Capital Group II, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Indirect	By: Hopkins Capital Group II, LLC

Footnotes

Restricted stock grant acquired pursuant to the Issuer's plan of compensation for Employees. The restricted stock grant was effective and immediately vested upon effective date of the Issuer's Bankruptcy Plan of Reorganization and the closing of a capital raise by the Issuer's with gross proceeds of a minimum of $5.0 million.
Represents acquisition of common stock of Accentia Biopharmaceuticals, Inc. by Hopkins Capital Group II, LLC from a third-party in a private transaction.
The reporting person is the manager of Hopkins Capital Group II, LLC and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.